BioCentury
ARTICLE | Clinical News

Betafectin PGG-glucan carbohydrate immunotherapeutic: Filed IND for a randomized, double-blind Phase I trial in 25 healthy volunteers, to be treated with or wit

August 28, 1995 7:00 AM UTC

Alpha-Beta Technology Inc. (ABTI), Worcester, Mass. Product: Betafectin PGG-glucan carbohydrate immunotherapeutic Indication: Mobilize peripheral blood precursor cells for reconstituting marrow after ...